Twelve Bio

Description: Twelve Bio develops CRISPR-Cas12a tech to detect & edit DNA sequences, enabling precise diagnostics & therapeutic applications.

Country: Denmark

Based in: Copenhagen

Founded: 2019

Funding Stage: Seed

Tags: ['Biotechnology', 'Health Diagnostics', 'Predictive Analytics']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.